Took a half normal position on Friday at $4.515, but, on reflection, think I bought too soon. Too close to the eye of the storm. Oh well, win some, lose some.....
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025